Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (255)
PRECIGEN, INC. (PGEN)
Tennant Phil — Chief Commercial Officer
Shares
79,166
Price
$7.50
Total Value
$593.75K
Shares Held After
141,992
% of Holdings
35.8%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
15,342
Price
$7.50
Total Value
$115.06K
Shares Held After
468,865
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,305
Price
$513.35
Total Value
$669.92K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,592
Price
$512.46
Total Value
$1.84M
Shares Held After
325,748
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,056
Price
$511.63
Total Value
$1.56M
Shares Held After
329,340
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,323
Price
$510.52
Total Value
$675.42K
Shares Held After
332,396
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
224
Price
$509.41
Total Value
$114.11K
Shares Held After
333,719
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
330
Price
$6.98
Total Value
$2.30K
Shares Held After
51,851
% of Holdings
0.6%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
125,000
Price
$26.91
Total Value
$3.36M
Shares Held After
69,302
% of Holdings
64.3%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
107,374
Price
$1.75
Total Value
$188.36K
Shares Held After
4,853,818
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
53,613
Price
$10.64
Total Value
$570.44K
Shares Held After
1,373,397
% of Holdings
3.9%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
25,000
Price
$65.07
Total Value
$1.63M
Shares Held After
37,025
% of Holdings
40.3%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
479,194
% of Holdings
20.9%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,437
Price
$25.98
Total Value
$193.19K
Shares Held After
38,400
% of Holdings
16.2%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
34,658
Price
$7.50
Total Value
$259.94K
Shares Held After
465,012
% of Holdings
6.9%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
29,697
Price
$2.12
Total Value
$62.96K
Shares Held After
488,267
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
41,832
Price
$69.09
Total Value
$2.89M
Shares Held After
174,606
% of Holdings
19.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
31,799
Price
$69.09
Total Value
$2.20M
Shares Held After
216,438
% of Holdings
12.8%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,457
Price
$15.54
Total Value
$22.64K
Shares Held After
16,220
% of Holdings
8.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$212.06
Total Value
$26.72K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
229
Price
$211.46
Total Value
$48.43K
Shares Held After
61,550
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$210.40
Total Value
$26.51K
Shares Held After
61,779
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,405
Price
$209.27
Total Value
$294.02K
Shares Held After
61,905
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
937
Price
$208.36
Total Value
$195.23K
Shares Held After
63,310
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
177
Price
$207.25
Total Value
$36.68K
Shares Held After
64,247
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
127
Price
$212.06
Total Value
$26.93K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
245
Price
$211.47
Total Value
$51.81K
Shares Held After
61,551
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
136
Price
$210.40
Total Value
$28.61K
Shares Held After
61,796
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,351
Price
$209.28
Total Value
$282.74K
Shares Held After
61,932
% of Holdings
2.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
951
Price
$208.36
Total Value
$198.15K
Shares Held After
63,283
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
190
Price
$207.25
Total Value
$39.38K
Shares Held After
64,234
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,621
Price
$212.08
Total Value
$767.93K
Shares Held After
267,330
% of Holdings
1.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
6,583
Price
$211.33
Total Value
$1.39M
Shares Held After
270,951
% of Holdings
2.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,813
Price
$210.25
Total Value
$801.67K
Shares Held After
277,534
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
35,938
Price
$209.26
Total Value
$7.52M
Shares Held After
281,347
% of Holdings
11.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
24,917
Price
$208.37
Total Value
$5.19M
Shares Held After
317,285
% of Holdings
7.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
5,128
Price
$207.23
Total Value
$1.06M
Shares Held After
342,202
% of Holdings
1.5%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
989
Price
$15.54
Total Value
$15.37K
Shares Held After
16,816
% of Holdings
5.6%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
9,589
Price
$15.54
Total Value
$149.01K
Shares Held After
63,899
% of Holdings
13.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,314
Price
$212.06
Total Value
$702.76K
Shares Held After
55,907
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
4,500
Price
$211.34
Total Value
$951.04K
Shares Held After
59,221
% of Holdings
7.1%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
2,540
Price
$210.26
Total Value
$534.07K
Shares Held After
63,721
% of Holdings
3.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
25,817
Price
$209.25
Total Value
$5.40M
Shares Held After
66,261
% of Holdings
28.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
17,323
Price
$208.37
Total Value
$3.61M
Shares Held After
92,078
% of Holdings
15.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,400
Price
$207.24
Total Value
$704.60K
Shares Held After
109,401
% of Holdings
3.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,871
Price
$15.00
Total Value
$43.07K
Shares Held After
90,180
% of Holdings
3.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
716,369
Price
$1.77
Total Value
$1.27M
Shares Held After
4,746,444
% of Holdings
15.1%
Arcus Biosciences, Inc. (RCUS)
Azoy Alexander — Chief Accounting Officer
Shares
2,827
Price
$30.00
Total Value
$84.81K
Shares Held After
39,581
% of Holdings
6.7%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
4,345
Price
$11.89
Total Value
$51.66K
Shares Held After
169,269
% of Holdings
2.5%
Showing 1–50 of 255 transactions (page 1 of 6)